Skip to main content

Advertisement

Table 2 Angiographic and procedural characteristics

From: Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Characteristics DM P No-DM P
G2‑DES N = 1862 BP‑DES N = 421 G2‑DES N = 4232 BP‑DES N = 1151
Lesions involving LM 46 (2.5) 9 (2.1) 0.688 81 (1.9) 15 (1.3) 0.165
Lesions involving LAD 1703 (91.5) 377 (89.5) 0.213 3929 (92.8) 1050 (91.2) 0.065
Lesions involving LCX 308 (16.5) 56 (13.3) 0.101 565 (13.4) 163 (14.2) 0.476
Lesions involving RCA 373 (20.0) 94 (22.3) 0.292 713 (16.8) 183 (15.9) 0.444
Number of lesions treated 1.4 ± 0.6 1.4 ± 0.6 0.664 1.3 ± 0.59 1.34 ± 0.60 0.013
Number of stents 1.8 ± 1.0 1.7 ± 0.9 0.177 1.75 ± 0.89 1.67 ± 0.88 0.391
Number of target vessel
 Single vessel 386 (20.7) 70 (16.6) 0.057 1320 (31.2) 340 (29.5) 0.282
 Double vessel 576 (30.9) 143 (34.0) 0.578 1316 (31.1) 379 (32.9) 0.236
 Triple vessel 779 (41.8) 185 (43.9) 0.429 1349 (31.9) 378 (32.8) 0.534
SYNTEX score 11.7 ± 8.0 11.9 ± 8.2 0.684 10.9 ± 7.7 11.0 ± 7.8 0.329
Normal origin of coronary artery 1774 (95.3) 403 (95.7) 0.692 4051 (95.7) 1102 (95.7) 0.977
Right distribution of coronary artery 1633 (87.7) 382 (90.7) 0.081 3747 (88.5) 1019 (88.5) 0.994
Transradial approach 1664 (89.4) 375 (89.1) 0.861 3813 (90.1) 1011 (87.8) 0.026
Pulling out sheath directly 1408 (75.6) 328 (77.9) 0.320 3277 (77.4) 904 (78.5) 0.424
IVUS application 97 (5.2) 16 (3.8) 0.229 218 (5.2) 58 (5.0) 0.878
IABP application 25 (1.3) 5 (1.2) 0.801 40 (0.9) 12 (1.0) 0.765
TIMI flow before PCI
 0 321 (17.2) 71 (16.9) 0.995 678 (16.0) 235 (20.4) < 0.001
 1 61 (3.3) 20 (4.8) 0.626 123 (2.9) 35 (3.0) 0.811
 2 221 (11.9) 36 (8.6) 0.290 483 (11.4) 125 (10.9) 0.599
 3 1259 (67.6) 294 (69.8) 0.247 2948 (69.7) 756 (65.7) 0.010
TIMI flow after PCI
 0 21 (1.1) 6 (1.4) 0.593 41 (1.0) 12 (1.0) 0.822
 1 3 (0.2) 0 (0) > 0.999 9 (0.2) 3 (0.3) 0.728
 2 10 (0.5) 4 (1.0) 0.226 30 (0.7) 11 (1.0) 0.393
 3 1828 (98.2) 411 (97.6) 0.754 4152 (98.1) 1125 (97.7) 0.425
B2 or C lesions 1430 (76.8) 330 (78.4) 0.484 3101 (73.3) 885 (76.9) 0.013
severe calcification 72 (3.9) 13 (3.1) 0.446 115 (2.7) 29 (2.5) 0.712
CTO lesions 143 (7.7) 30 (7.1) 0.698 267 (6.3) 107 (9.3) < 0.001
Ostial lesions 316 (17.0) 66 (15.7) 0.521 697 (16.5) 178 (15.5) 0.413
Bifurcation lesions 346 (18.6) 77 (18.3) 0.889 825 (19.5) 239 (20.8) 0.337
Thrombosis 67 (3.6) 15 (3.6) 0.972 173 (4.1) 50 (4.3) 0.699
  1. DM diabetes mellitus, BP-DES biodegradable polymer drug-eluting stents, G2-DES second generation drug-eluting stents, LM left main, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, SYNTEX synergy between percutaneous coronary interventions with TAXUS and cardiac surgery, IVUS intravascular ultrasound, IABP intra-aortic balloon pump, TIMI thrombolysis in myocardial infarction, PCI percutaneous coronary intervention, CTO chronic total occlusion